Lupus carditis: Evaluation with technetium-99m MIBI myocardial SPECT and heart rate variability

Angiology

Volumn 50, Issue 2, 1999, Pages 143-148

  Laganà, Bruno ^a,b   Schillaci, Orazio ^a   Tubani, Luigi ^a   Gentile, Raffaele ^a   Danieli, Roberta ^a   Coviello, Rossella ^a   Baratta, Luigi ^a   Scopinaro, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b c/o Department of Medicina Clinica ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; AUTONOMIC NERVOUS SYSTEM; CARDITIS; CLINICAL ARTICLE; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART DISEASE; HEART MUSCLE CONTRACTILITY; HEART PERFUSION; HEART RATE VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUPUS ERYTHEMATOSUS; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0033048828     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979905000208     Document Type: Article

References (29)

1. Urowitz MB, Bookman AAM, Koehler BE, et al: The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221-225, 1976.
2. Wallace DJ, Poddel T, Weiner J, et al: Systemic lupus erythematosus - survival pattern. Experience with 609 patients. JAMA 245:934-938, 1981.
3. Bonomo L, Laganà B, Mitterhofer AP: Echocardiographic evaluation of cardiovascular involvement in SLE. In: Frontiers in Autoimmune Diseases and Cancer Immunotherapy, ed. by F. Dammacco F. Milan: edi Ermes, 1991, pp 185-192.
4. Laganà B, Tubani L, Maffeo N, et al: Heart rate variability and cardiac autonomic function in systemic lupus erythematosus. Lupus 5:49-55, 1996.
5. Malpas SC, Gordon LP: Circadian variation of heart rate variability. Cardiovasc Res 24:210-213, 1990.
6. Stein KS, Mc Farlane IC, Goldberg N, et al: Heart rate variability in patients with systemic lupus erythematosus. Lupus 5:44-48, 1996.
7. Parodi O, Marcassa C, Casucci R, et al: Accuracy and safety of technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile (sestamibi) myocardial scintigraphy with high dose dipyridamole test in patients with effort angina pectoris: A multicenter study. J Am Coll Cardiol 18:1439-1444, 1991.
8. Kiat H, Maddahi J, Roy LT, et al: Comparison of technetium-99m-methoxy isobutyl isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 117:1-11, 1989.
9. Maddahi J, Rodrigues E, Berman DS, et al: State of the art myocardial perfusion imaging. Cardiol Clin 12:199-222, 1994.
10. Stein PK, Bosner MS, Kleiger RF, et al: Heart rate variability: A measure of cardiac autonomic tone. Am Heart J 127:1376-1380, 1994.
11. Beller GA, Watson DD: Physiological basis of myocardial perfusion imaging with the technetium-99m agents. Semin Nucl Med 21:173-181, 1991.
12. Cuocolo A, Soricelli A, Pace L: Adenosine technetium-99m methoxy isobutyl isonitrile myocardial tomography in patients with coronary artery disease: Comparison with exercise. J Nucl Med 33:1110-1115, 1994.
13. Klemperer P, Pollack AD, Baehr G: Pathology of disseminated lupus erythematosus. Arch Pathol 32:569-631, 1941.
14. Brigden W, Bywaters EGL, Lessof MH, et al: The heart in systemic lupus erythematosus. Br Heart J 22:1-16, 1960.
15. Hejtmancik MR, Wright JC, Quint R, et al: The cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 68:119-130, 1964.
16. Bulkley BH, Roberts WC: The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. Am J Med 58:243-264, 1975.
17. Doherty NE, Siegel RJ: Cardiovascular manifestations of systemic lupus erythematosus by prospective analysis. Am Heart J 110:1257-1265, 1985.
18. Mandell BF: Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 17:126-141, 1987.
19. Sasson Z, Rasooly Y, Chow CW, et al: Impairment of left ventricular diastolic function in systemic lupus erythematosus. Am J Cardiol 69:1629-1634, 1992.
20. Sakaguchi Y, Nakamura Y, Sutani T, et al: Immunohistochemical study of the endomyocardial biopsy of systemic lupus erythematosus. J Cardiol 25:181-188, 1995.
21. Leung WH, Wong KL, Lau CP, et al: Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 89:411-419, 1990.
22. Gomez P, Oakley CM: Association between cardiac abnormalities and raised anticardiolipin antibodies in systemic lupus erythematosus. Postgrad Med J 64:723, 1988 (abstract).
23. Hamsten A, Norberg R, Bjorkhom M, et al: Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events. Lancet 1:113-115, 1986.
24. Murphy JJ, Leach IH: Findings at necropsy in the heart of a patient with anticardiolipin syndrome. Br Heart J 62:61-64, 1989.
25. Zafrir N, Bassevitch R, Shimoni A, et al: Effect of dipyridamole on myocardial perfusion and function using technetium-99m MIBI. Int J Cardiol 49:25-31, 1995.
26. Dilsiazian V, Anigh JA, Diodati JG, et al: Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc sestamibi with thallium reinjection and 18F fluideoxyglucose. Circulation 89:578-580, 1994.
27. Hosenpud JD, Montanaro A, Hart MV, et al: Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am J Med 77:286-292, 1984.
28. Chiu ML, Kronauge JF, Piwnica-Worms D: Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblast. J Nucl Med 31:1646-1653, 1990.
29. Carvalho PA, Chiu ML, Kronauge JF, et al: Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 33:1516-1521, 1992.